Repligen reported $55.91M in Pre-Tax Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Align Technology ALGN:US $ 261.99M 6.81M
Bristol Myers Squibb BMY:US $ 5289M 67M
Bruker BRKR:US $ 121M 27.8M
Exact Sciences EXAS:US $ -170.8M 2.09M
Fluidigm FLDM:US $ -15.26M 2.4M
Genesis Healthcare GEN:US $ -19.35M 76.4M
Illumina ILMN:US $ 254M 82M
IQVIA Holdings Inc IQV:US $ 533M 8M
Luminex LMNX:US $ 11.04M 5.81M
Nanostring Technologies NSTG:US $ -31.32M 4.38M
Orasure Technologies OSUR:US $ -12.91M 15.16M
Pacific Biosciences Of California PACB:US $ -78.28M 37.28M
Peregrine Pharmaceuticals PPHM:US $ 3.52M 2.78M
Repligen RGEN:US $ 55.91M 0.3M